These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15055989)
1. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases. Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989 [TBL] [Abstract][Full Text] [Related]
2. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases. Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398 [TBL] [Abstract][Full Text] [Related]
4. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases). James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8. James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341 [TBL] [Abstract][Full Text] [Related]
6. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases. Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671 [TBL] [Abstract][Full Text] [Related]
7. Specificity of aza-peptide electrophile activity-based probes of caspases. Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749 [TBL] [Abstract][Full Text] [Related]
8. Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens. Götz MG; James KE; Hansell E; Dvorák J; Seshaadri A; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC J Med Chem; 2008 May; 51(9):2816-32. PubMed ID: 18416543 [TBL] [Abstract][Full Text] [Related]
11. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases. Löser R; Frizler M; Schilling K; Gütschow M Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765 [No Abstract] [Full Text] [Related]
12. A general solid phase method for the preparation of diverse azapeptide probes directed against cysteine proteases. Kato D; Verhelst SH; Sexton KB; Bogyo M Org Lett; 2005 Dec; 7(25):5649-52. PubMed ID: 16321013 [TBL] [Abstract][Full Text] [Related]
13. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. Schirmeister T J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963 [TBL] [Abstract][Full Text] [Related]
14. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors. Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease. Venkatraman S; Kong J; Nimkar S; Wang QM; Aubé J; Hanzlik RP Bioorg Med Chem Lett; 1999 Feb; 9(4):577-80. PubMed ID: 10098667 [TBL] [Abstract][Full Text] [Related]
17. Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. Chen JM; Rawlings ND; Stevens RA; Barrett AJ FEBS Lett; 1998 Dec; 441(3):361-5. PubMed ID: 9891971 [TBL] [Abstract][Full Text] [Related]
18. Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. Wieczerzak E; Drabik P; Łankiewicz L; Ołdziej S; Grzonka Z; Abrahamson M; Grubb A; Brömme D J Med Chem; 2002 Sep; 45(19):4202-11. PubMed ID: 12213061 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones. Niestroj AJ; Feussner K; Heiser U; Dando PM; Barrett A; Gerhartz B; Demuth HU Biol Chem; 2002; 383(7-8):1205-14. PubMed ID: 12437107 [TBL] [Abstract][Full Text] [Related]
20. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases. Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]